MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Gastrointestinal transit time in Parkinson’s disease -a novel 3D method

    K. Knudsen, T. Fedorova, K. Østergaard, K. Krogh, P. Borghammer (Aarhus, Denmark)

    Objective: To study the GI transit time with a novel ambulatory electromagnetic system in PD patients and healthy controls. Background: The majority of Parkinson’s disease…
  • 2017 International Congress

    Pancreatic polypeptide plasma levels in Parkinson’s disease – a marker of parasympathetic denervation

    K. Knudsen, T. Fedorova, K. Østergaard, P. Borghammer (Aarhus, Denmark)

    Objective: To study plasma PP concentration during sham feeding in PD patients and healthy controls, as a measure of pancreatic vagal innervation. Background: Most patients…
  • 2017 International Congress

    Validation of the Utility of Brief Smell Identification Test Simplified Chinese Version 2 in Chinese Parkinson’s disease

    M. Cao (Beijing, China)

    Objective: To validate the utility and efficiency of Brief Smell Identification Test Simplified Chinese Version 2 (B-SIT CV2) in Chinese Parkinson's disease patients and investigate…
  • 2017 International Congress

    Circadian and Homeostatic Modulation of Multi-unit Activity in Dopaminergic and Striatal Structures

    K. Fifel (Leiden, Netherlands)

    Objective: The aim of this study is to investigate the circadian and homeostatic modulation of the multi-unit activity of dopamineric and striatal neuronal structures. Background:…
  • 2017 International Congress

    Correlation and impact of non-motor symptoms on intensity of motor symptoms in Parkinson’s Disease

    M. Sanoeva, M. Gulova, N. Mansurova (bukhara, Uzbekistan)

    Objective: Tha aim of the study was to determine the relationship between the development of non-motor symptoms in the development of motor deficitis in patients…
  • 2017 International Congress

    Heart rate variability in Parkinson’s Disease and idiopathic REM sleep behavior disorder and relation with other non-motor symptoms

    P. Bugalho, M. Mendonça, T. Lampreia, R. Miguel, R. Barbosa, M. Salavisa (Lisbon, Portugal)

    Objective: To evaluate Heart Rate Variability (HRV) changes across sleep stages in Parkinson's Disease (PD) and idiopathic REM Sleep Behavior disorder (RBD) patients, and to…
  • 2017 International Congress

    Assessment of pain in Parkinson’s disease: comparison between clinical and self-reported measures

    C. Rodriguez-Blazquez, R. Balestrino, K. Chaudhuri, J.M. Rojo-Abuin, A. Rizos, C. Trenkwalder, A. Sauerbier, P. Odin, A. Antonini, P. Martinez-Martin (Madrid, Spain)

    Objective: To compare the performance of several pain measures, self- and rater-based, in PD patients. Background: Pain is a prevalent and complex symptom in Parkinson’s…
  • 2017 International Congress

    Predicting the onset of freezing of gait: A longitudinal study

    K. Ehgoetz Martens, E. Lukasik, M. Georgiades, M. Gilat, J. Hall, C. Walton, S. Lewis (Camperdown, Australia)

    Objective: This prospective cohort study sought to examine longitudinal data spanning the transition period where PD patients developed FOG to identify symptoms that may precede…
  • 2017 International Congress

    Assessment of Autonomic Dysfunction in Parkinson’s Disease

    K. Karbozova, , (Bishkek, Kyrgyzstan)

    Objective: Assessment of autonomic dysfunction in patients with Parkinson's disease and further comparison with patients without autonomic symptoms Background: A frequent disabling complication of Parkinson’s…
  • 2017 International Congress

    Association of impaired melatonin secretion with sleep disturbance in Parkinson’s disease

    T. Nakamura, M. Suzuki, M. Ueda, E. Imai, G. Tohnai, M. Katsuno (Nagoya, Japan)

    Objective: To clarify if impaired melatonin secretion is associated with daytime or nighttime sleep disturbances in patients with Parkinson’s disease (PD). Background: PD is associated…
  • « Previous Page
  • 1
  • …
  • 1197
  • 1198
  • 1199
  • 1200
  • 1201
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25676 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley